{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:59:59Z","timestamp":1791950399739,"version":"4.3.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2014,11,7]],"date-time":"2014-11-07T00:00:00Z","timestamp":1415318400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s00059-014-4147-5","type":"journal-article","created":{"date-parts":[[2014,11,5]],"date-time":"2014-11-05T07:36:34Z","timestamp":1415172994000},"page":"1-7","source":"Crossref","is-referenced-by-count":24,"title":["Apolipoprotein B\/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol","Verh\u00e4ltnis von Apolipoprotein\u00a0B zu Apolipoprotein\u00a0A1 und Nicht-HDL-Cholesterin"],"prefix":"10.1007","volume":"40","author":[{"given":"P.","family":"Liting","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Guoping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Zhenyue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,7]]},"reference":[{"key":"4147_CR1","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","author":"Expert","year":"2002","unstructured":"Expert Panel (2002) Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 106:3143\u20133421","journal-title":"Circulation"},{"key":"4147_CR2","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/S0140-6736(01)07098-2","volume":"358","author":"Walldius","year":"2001","unstructured":"Walldius G, Jungner I, Holme I et al (2001) High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 358:2026\u20132033","journal-title":"Lancet"},{"key":"4147_CR3","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"Yusuf","year":"2004","unstructured":"Yusuf S, Hawken S, Ounpuu S et al (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case\u2014control study. Lancet 364:937\u2013952","journal-title":"Lancet"},{"key":"4147_CR4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2796.2006.01643.x","volume":"259","author":"Walldius","year":"2006","unstructured":"Walldius G, Jungner I (2006) The apoB\/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy\u2014a review of the evidence. J Intern Med 259:493\u2013519","journal-title":"J Intern Med"},{"key":"4147_CR5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2796.2006.01644.x","volume":"259","author":"Thompson","year":"2006","unstructured":"Thompson A, Danesh J (2006) Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B\/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies. J Intern Med 259:481\u2013492","journal-title":"J Intern Med"},{"key":"4147_CR6","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.amjcard.2007.11.046","volume":"101","author":"Miller","year":"2008","unstructured":"Miller M, Ginsberg HN, Schaefer EJ (2008) Relative atherogenicity and predictive value of non-high-density lipoprotein cholesterol for coronary heart disease. Am J Cardiol 101:1003\u20131008","journal-title":"Am J Cardiol"},{"key":"4147_CR7","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jacc.2008.10.024","volume":"53","author":"Robinson","year":"2009","unstructured":"Robinson JG, Wang S, Smith BJ, Jacobson TA (2009) Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk. J Am Coll Cardiol 53:316\u2013322","journal-title":"J Am Coll Cardiol"},{"key":"4147_CR8","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.atherosclerosis.2009.05.020","volume":"207","author":"Rosenson","year":"2009","unstructured":"Rosenson RS (2009) Management of non-high-density lipoprotein abnormalities. Atherosclerosis 207:328\u2013335","journal-title":"Atherosclerosis"},{"key":"4147_CR9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2337\/diacare.26.1.16","volume":"26","author":"Lu","year":"2003","unstructured":"Lu W, Resnick HE, Jablonski KA et al (2003) Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the Strong Heart study. Diabetes Care 26:16\u201323","journal-title":"Diabetes Care"},{"key":"4147_CR10","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.2337\/diacare.27.8.1991","volume":"27","author":"Jiang","year":"2004","unstructured":"Jiang R, Schulze MB, Li T et al (2004) Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes. Diabetes Care 27:1991\u20131997","journal-title":"Diabetes Care"},{"key":"4147_CR11","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1161\/CIRCULATIONAHA.105.588178","volume":"112","author":"Denke","year":"2005","unstructured":"Denke MA (2005) Weighing in before the fight: low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol versus apolipoprotein B as the best predictor for coronary heart disease and the best measure of therapy. Circulation 112:3368\u20133370","journal-title":"Circulation"},{"key":"4147_CR12","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1161\/CIRCULATIONAHA.105.583336","volume":"112","author":"Sniderman","year":"2005","unstructured":"Sniderman AD (2005) Apolipoprotein B versus non-high-density lipoprotein cholesterol: and the winner isy. Circulation 112:3366\u20133367","journal-title":"Circulation"},{"key":"4147_CR13","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/MCA.0000000000000100","volume":"25","author":"Pan","year":"2014","unstructured":"Pan L, Lu G, Chen Z (2014) Combined use of apolipoprotein B\/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol before routine clinical lipid measurement in predicting coronary heart disease. Coron Artery Dis 25(5):433\u2013438","journal-title":"Coron Artery Dis"},{"key":"4147_CR14","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1194\/jlr.M700213-JLR200","volume":"48","author":"Chien","year":"2007","unstructured":"Chien KL, Hsu HC, Su TC et al (2007) Apolipoprotein B and non-high density lipoprotein cholesterol and the risk of coronary heart disease in Chinese. J Lipid Res 48(11):2499\u20132505","journal-title":"J Lipid Res"},{"key":"4147_CR15","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0002-9149(83)80105-2","volume":"51","author":"Gensini","year":"1983","unstructured":"Gensini GG (1983) A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 51(3):606","journal-title":"Am J Cardiol"},{"key":"4147_CR16","first-page":"610","volume":"50","author":"Khadem-Ansari","year":"2009","unstructured":"Khadem-Ansari MH, Rasmi Y, Rahimi-Pour A et al (2009) The association between serum apolipoprotein A-I and apolipoprotein B and the severity of angiographical coronary artery disease. Singapore Med J 50(6):610\u2013613","journal-title":"Singapore Med J"},{"key":"4147_CR17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2796.2006.01648.x","volume":"259","author":"Marcovina","year":"2006","unstructured":"Marcovina S, Packard CJ (2006) Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels. J Intern Med 259:437\u2013446","journal-title":"J Intern Med"},{"key":"4147_CR18","doi-asserted-by":"crossref","first-page":"211e28","DOI":"10.1016\/S0022-2275(20)39898-9","volume":"36","author":"Fielding","year":"1995","unstructured":"Fielding CJ, Fielding PE (1995) Molecular physiology of reverse cholesterol transport. J Lipid Res 36:211e28","journal-title":"J Lipid Res"},{"key":"4147_CR19","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"Yusuf","year":"2004","unstructured":"Yusuf S, Hawken S, Ounpuu S et al (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTER-HEART Study): case-control study. Lancet 364:937\u2013952","journal-title":"Lancet"},{"key":"4147_CR20","doi-asserted-by":"crossref","first-page":"337e45","DOI":"10.1161\/CIRCOUTCOMES.110.959247","volume":"4","author":"Sniderman","year":"2011","unstructured":"Sniderman AD, Williams K, Contois JH et al (2011) A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk. Circ Cardiovasc Qual Outcomes 4:337e45","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"4147_CR21","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11745-007-3050-8","volume":"42","author":"Tsimihodimos","year":"2007","unstructured":"Tsimihodimos V, Gazi I, Kostara C et al (2007) Plasma lipoproteins and triacylglycerol are predictors of small, dense LDL particles. Lipids 42:403\u2013409","journal-title":"Lipids"},{"key":"4147_CR22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.atherosclerosissup.2006.05.004","volume":"7","author":"Sacks","year":"2006","unstructured":"Sacks FM (2006) The apolipoprotein story. Atheroscler Suppl 7:23\u201327","journal-title":"Atheroscler Suppl"},{"key":"4147_CR23","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1161\/CIRCULATIONAHA.104.532499","volume":"112","author":"Pischon","year":"2005","unstructured":"Pischon T, Girman CJ, Sacks FM et al (2005) Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation 112:3375\u20133383","journal-title":"Circulation"},{"key":"4147_CR24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.atherosclerosissup.2004.03.005","volume":"5","author":"Sniderman","year":"2004","unstructured":"Sniderman A, Williams K, Haffner S, Sattar N (2004) Insights from apoB: from better diagnosis and therapy to the Medusa hypothesis. Atheroscler Suppl 5:19\u201324","journal-title":"Atheroscler Suppl"},{"key":"4147_CR25","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/ATVBAHA.108.181735","volume":"29","author":"Ray","year":"2009","unstructured":"Ray KK, Christopher CP et al (2009) Prognostic utility of apoB\/AI, total cholesterol\/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after TIMI 22\u2014acute coronary syndromes: results from PROVE IT-TIMI 22. Arterioscler Thromb Vasc Biol 29:424\u2013430","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4147_CR26","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1185\/030079907X253906","volume":"24","author":"Liem","year":"2008","unstructured":"Liem AH, Woestijne AP van de et al (2008) ApoB\/A1 and LDL-C\/HDL-C and the prediction of cardiovascular risk in statin-treated patients. Curr Med Res Opin 24(2):359\u2013364","journal-title":"Curr Med Res Opin"},{"key":"4147_CR27","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3346\/jkms.2013.28.5.709","volume":"28","author":"Jung","year":"2013","unstructured":"Jung CH, Hwang JY, Shin MS et al (2013) Association of apolipoprotein b\/apolipoprotein A1 ratio and coronary artery stenosis and plaques detected by multi-detector computed tomography in healthy population. J Korean Med Sci 28:709\u2013716","journal-title":"J Korean Med Sci"},{"key":"4147_CR28","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.CIR.92.5.1355","volume":"92","author":"Stary","year":"1995","unstructured":"Stary HC, Chandler AB, Dinsmore RE et al (1995) A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 92:1355\u20131374","journal-title":"Circulation"},{"key":"4147_CR29","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.jacc.2006.01.041","volume":"47","author":"Hoffmann","year":"2006","unstructured":"Hoffmann U, Moselewski F, Nieman K et al (2006) Noninvasive assessment of plaque morphology and composition in culprit and stable lesions in acute coronary syndrome and stable lesions in stable angina by multidetector computed tomography. J Am Coll Cardiol 47:1655\u20131662","journal-title":"J Am Coll Cardiol"},{"key":"4147_CR30","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1161\/01.CIR.0000097121.95451.39","volume":"108","author":"Fujii","year":"2003","unstructured":"Fujii K, Kobayashi Y, Mintz GS et al (2003) Intravascular ultrasound assessment of ulcerated ruptured plaques: a comparison of culprit and nonculprit lesions of patients with acute coronary syndromes and lesions in patients without acute coronary syndromes. Circulation 108:2473\u20132478","journal-title":"Circulation"}],"container-title":["Herz"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-014-4147-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00059-014-4147-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-014-4147-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T08:01:35Z","timestamp":1650528095000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00059-014-4147-5"}},"subtitle":["Predictive value for CHD severity and prognostic utility in CHD patients","Pr\u00e4diktiver Wert f\u00fcr den Schweregrad der KHK und prognostischer Nutzen bei KHK-Patienten"],"short-title":[],"issued":{"date-parts":[[2014,11,7]]},"references-count":30,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["4147"],"URL":"https:\/\/doi.org\/10.1007\/s00059-014-4147-5","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,7]]}}}